Adlai Nortye (NASDAQ:ANL) Trading 1% Higher – What’s Next?

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) shares shot up 1% during mid-day trading on Wednesday . The company traded as high as $1.55 and last traded at $1.5350. 11,895 shares changed hands during mid-day trading, a decline of 63% from the average session volume of 31,907 shares. The stock had previously closed at $1.52.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Adlai Nortye in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Adlai Nortye presently has an average rating of “Reduce”.

Adlai Nortye Trading Up 1.0%

The business has a fifty day simple moving average of $1.46 and a 200 day simple moving average of $1.57.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.